Atlas Trials

Artificial Tears to Prevent Nasolacrimal Duct Obstruction in Patients Treated With Radioactive Iodine for Thyroid Cancer

Clinical trial NCT05999630 · RECRUITING

Trial details

NCT number
NCT05999630
Sponsor
Vanderbilt University Medical Center
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Nasolacrimal Duct ObstructionThyroid Cancer
Start date
2023-08-21
Primary completion
2027-12-31
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.